Institute of Nutrition and Functional Foods, Laval University, 2440, boul. Hochelaga, Québec (Qc), Canada, G1V 0A6.
Metabolism. 2013 Dec;62(12):1803-10. doi: 10.1016/j.metabol.2013.07.012. Epub 2013 Aug 29.
While a Mediterranean dietary pattern (MedDiet) has been associated with favorable changes in several features of metabolic syndrome (MetS), its impact on plasma adipokine concentrations remains largely unknown. The objective of this study was to determine the impact of the MedDiet consumed under controlled feeding conditions, without (-WL) and with weight loss (+WL), on plasma adipokine concentrations in adult men with MetS (NCEP-ATP III).
MATERIALS/METHODS: The diet of 26 men with MetS (age 24 to 62 yrs) was first standardized to a North American control diet for 5 weeks. Participants then consumed a pre-determined MedDiet for 5 weeks. Both diets were consumed under weight-maintaining isoenergetic feeding conditions. Participants then underwent a 20-week free-living caloric restriction period, after which they consumed the MedDiet again in weight stabilizing, isoenergetic feeding conditions.
Body weight was reduced by 10.2%±2.9% and waist circumference by 8.6±3.3 cm after the weight loss period and stabilization on MedDiet (P<0.001). MedDiet-WL had no impact on plasma concentrations of leptin, plasminogen activator inhibitor-1, resistin, visfatin, acylation stimulating protein and adiponectin. MedDiet+WL reduced plasma leptin concentrations (P<0.01) and increased plasma adiponectin concentrations (P<0.05) compared with the control diet and MedDiet-WL.
Data from this nutritionally controlled study suggest that short-term consumption of MedDiet has little effect on the concentrations of many adipokines in the absence of weight loss.
尽管地中海饮食模式(MedDiet)与代谢综合征(MetS)的几个特征的有利变化有关,但它对血浆脂肪因子浓度的影响在很大程度上仍然未知。本研究的目的是确定在受控喂养条件下,不(-WL)和减肥(+WL)下,地中海饮食对代谢综合征(NCEP-ATP III)成年男性血浆脂肪因子浓度的影响。
材料/方法:首先,将 26 名患有代谢综合征的男性(年龄 24 至 62 岁)的饮食标准化为 5 周的北美对照饮食。然后,参与者连续 5 周食用预定的地中海饮食。两种饮食均在维持能量的等能喂养条件下食用。然后,参与者经历了 20 周的自由生活热量限制期,之后他们再次在稳定体重的等能喂养条件下食用地中海饮食。
体重减轻了 10.2%±2.9%,腰围减少了 8.6±3.3 厘米,减肥期和地中海饮食稳定后(P<0.001)。地中海饮食-WL 对血浆瘦素、纤溶酶原激活物抑制剂-1、抵抗素、内脂素、酰基辅酶 A 合成蛋白和脂联素的浓度没有影响。与对照饮食和地中海饮食-WL 相比,地中海饮食+WL 降低了血浆瘦素浓度(P<0.01)并增加了血浆脂联素浓度(P<0.05)。
这项营养控制研究的数据表明,在没有减肥的情况下,短期食用地中海饮食对许多脂肪因子的浓度影响不大。